Upper tract urothelial carcinoma following intravesical bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: Results from a multi-institutional retrospective study
Urologic Oncology: Seminars and Original Investigations Mar 27, 2018
Nishiyama N, et al. - The prognostic indicators for upper tract urothelial carcinoma (UTUC) after intravesical bacillus Calmette-Guerin (BCG) therapy for non-muscle-invasive bladder cancer (NMIBC) were determined. Two independent predicting factors (intravesical recurrence and non-papillary non-pedunculated at TURBT before BCG) were identified for UTUC.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
